PUBLISHER: The Business Research Company | PRODUCT CODE: 2009571
PUBLISHER: The Business Research Company | PRODUCT CODE: 2009571
Diagnostic tools are instruments and systems used to identify diseases, abnormalities, or medical conditions by collecting and analyzing relevant health data. They support accurate assessment of underlying causes and enable timely intervention. These tools contribute to early detection, improved clinical precision, and informed treatment planning.
The main components of diagnostic tools include software and services. Software consists of digital platforms and applications that support the analysis, interpretation, and management of diagnostic data. These solutions are delivered through on premises and cloud based models and serve organizations of various sizes including small and medium enterprises and large enterprises. Applications extend across banking, financial services and insurance, information technology and telecommunications, healthcare, retail, manufacturing, government, and other industries.
Tariffs on imported diagnostic equipment, laboratory analyzers, and imaging devices are impacting the diagnostic tools market by increasing procurement costs and slowing equipment deployment, particularly in segments like blood glucose monitoring systems and hematology analyzers. Regions such as North America and Europe, which depend heavily on imports from Asia-Pacific manufacturing hubs, are most affected. Despite increased costs, tariffs have also stimulated local manufacturing, encouraged domestic innovation, and accelerated the development of cost-efficient diagnostic solutions, providing a positive long-term impact on market resilience.
The diagnostic tools market research report is one of a series of new reports from The Business Research Company that provides diagnostic tools market statistics, including diagnostic tools industry global market size, regional shares, competitors with a diagnostic tools market share, detailed diagnostic tools market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic tools industry. This diagnostic tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diagnostic tools market size has grown strongly in recent years. It will grow from $43.96 billion in 2025 to $46.41 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising demand for early disease detection, growth in healthcare infrastructure, adoption of laboratory testing devices, increasing government healthcare initiatives.
The diagnostic tools market size is expected to see strong growth in the next few years. It will grow to $58.21 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to growing telemedicine adoption, rising investment in AI-driven diagnostics, expansion of wearable health monitoring devices, increasing focus on personalized medicine, growth in preventive healthcare services. Major trends in the forecast period include increasing adoption of remote patient monitoring tools, rising demand for point-of-care diagnostic devices, growth in imaging and radiology evaluation services, expansion of laboratory testing and sample analysis solutions, integration of multi-parameter health screening systems.
The increasing prevalence of infectious diseases is expected to propel the growth of the diagnostic tools market going forward. Infectious diseases are illnesses caused by pathogens that spread between people, animals, or environments. Growth is driven by urbanization and population expansion, which increase close interactions and accelerate transmission. Diagnostic tools support disease management by rapidly identifying causative pathogens, enabling early treatment and containment. In March 2024, the Centers for Disease Control and Prevention reported tuberculosis cases rising from 8320 in 2022 to 9615 in 2023, an increase of 1295 cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the diagnostic tools market.
Leading vendors in the diagnostic tools market are focusing on digital pathology platforms to enable faster and more accurate disease detection while streamlining clinical workflows. A digital pathology platform digitizes tissue samples and biopsy slides using high resolution scanners, allowing pathologists to analyze and share images through computer or cloud based systems often enhanced with artificial intelligence tools. For instance, in June 2025, PathAI Inc., a United States based technology company, launched AISight Dx, a digital pathology image management system approved by the Food and Drug Administration for primary diagnosis in clinical settings. The system supports intelligent case management, high performance whole slide image review, multi slide navigation, annotation, and collaboration while integrating with scanners such as Hamamatsu NanoZoomer and Leica Aperio to enhance diagnostic efficiency and consistency.
In October 2025, ARCHIMED Diagnostics, a France based healthcare focused investment firm, completed the acquisition of ARK Diagnostics for an undisclosed amount. Through this acquisition, ARCHIMED aimed to expand its presence in the in vitro diagnostics market by strengthening ARK Diagnostics specialized assay portfolio and improving its global distribution capabilities in therapeutic drug monitoring and clinical toxicology testing. ARK Diagnostics is a US based company that manufactures diagnostic tools, particularly in vitro diagnostic assay kits used for clinical diagnostics.
Major companies operating in the diagnostic tools market are F Hoffmann La Roche AG, Hitachi Ltd, Abbott Laboratories, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips NV, Fujifilm Holdings Corporation, Danaher Corporation, GE HealthCare Technologies Inc, Becton Dickinson and Company, Konica Minolta Inc, Shenzhen Mindray Bio Medical Electronics Co Ltd, Illumina Inc, bioMerieux SA, Hologic Inc, Shimadzu Corporation, Bio Rad Laboratories Inc, DiaSorin SpA, Carestream Health Inc, and Sanrad Medical Systems Private Limited.
North America was the largest region in the diagnostic tools market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic tools market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the diagnostic tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diagnostic tools market consists of revenues earned by entities by providing services such as screening and preventive health assessments, disease monitoring and progression tracking, laboratory testing and sample analysis, and imaging and radiology evaluation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic tools market also includes sales of electroencephalogram (EEG) systems, spirometers, blood glucose monitoring devices, and hematology analyzers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diagnostic Tools Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses diagnostic tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for diagnostic tools ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic tools market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.